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GENERAL COMMENTS
This protocol is proposed for the development of a new method for analysis of the IHC-based immune pattern in primary tissue and near lymph nodes. In the final part of the proposed protocol the authors propose also the merging and combining the single cell-type outcome of the automated IHC quantification of each immune cell pattern into a immune signature that could predict prognosis. The novelty of this study is the systematic study of such immune pattern in both primary and near lymph node and potential link to clinical outcome. My comments for the authors in order to increase the impact of such study protocol for the readers of the journal General comments and suggestions:
1. To my knowledge there is nowadays existing literature addressing the IHC image analysis for automating the quantification of IHC/FISH labeled molecular expression of various molecules. In the proposed protocol the part 7 in the material and method is very lightly covered given the scope of the protocol (is after all a protocol to develop a method of analysis of IHC digital slides!). I think this section could be developed based on more thorough review of the literature and giving concrete step-by-step based methodology on how one could develop such a method. Considerations to take into account. To my opinion this is a crucial piece of information for such a protocol. 2. Moving on to the next step of merging of the results, the statistical steps of how one can merge the output for each immunomarker (and also references for the interested reader) in particular taking into consideration missing tissue cores (very often happening to due to the cutting of the PFE blocks and the automated localization of the TMA spots) or handling of tissue cores with little tissue. In the same paragraph authors could develop the quality control of the TMA IHC staining for sub-optimal IHC staining / counterstaining and tissue processing artifacts such as tissue folding. All this aspects are very important for the data integration part of such a analysis workflow. 3. In the final part the protocol, the part of the combination of the different immune cell pattern response is not described clearly enough in order to complete the protocol with enough detail to be followed and used by an interested reader. It would be very interesting for the reader to see a more detailed step-by 
VERSION 1 -AUTHOR RESPONSE
Reviewer: To my knowledge there is nowadays existing literature addressing the IHC image analysis for automating the quantification of IHC/FISH labeled molecular expression of various molecules. In the proposed protocol the part 7 in the material and method is very lightly covered given the scope of the protocol (is after all a protocol to develop a method of analysis of IHC digital slides!). I think this section could be developed based on more thorough review of the literature and giving concrete stepby-step based methodology on how one could develop such a method. Considerations to take into account. To my opinion this is a crucial piece of information for such a protocol.
Author: Our research group has previous experience developing procedures for IHC digital image analysis. In this protocol, we will use part of these previous procedures and we will adapt them according to the new markers to evaluate. This fact is now commented in the protocol: page 12 lines 10-11 and lines 27-30 and page 13 lines 1-4. There you will see that we have mentioned several works of our group where it is possible to find different image analysis procedure developments deeply explained step-by-step and provided with several examples.
Reviewer: Moving on to the next step of merging of the results, the statistical steps of how one can merge the output for each immunomarker (and also references for the interested reader) in particular taking into consideration missing tissue cores (very often happening to due to the cutting of the PFE blocks and the automated localization of the TMA spots) or handling of tissue cores with little tissue. In the same paragraph authors could develop the quality control of the TMA IHC staining for suboptimal IHC staining / counterstaining and tissue processing artefacts such as tissue folding. All this aspects are very important for the data integration part of such an analysis workflow.
